Interferon needed for cells to ‘remember’ how to defeat a virus
Cardiovascular conditions leading to heart attacks and strokes are treated quite separately from common cancers of the prostate, breast or lung, but now turn out to involve some of the same critical mechanisms at the molecular level. This in turn provides clues to more effective therapies for both cancer and cardiovascular diseases, but requires researchers
Full Post: Mechanisms of cardiovascular disease and cancer give clues to new therapies
Scientists at UT Southwestern Medical Center have determined that the immune-system protein interferon plays a key role in “teaching” the immune system how to fight off repeated infections of the same virus.
The findings, available online and in the Dec. 15 issue of the Journal of Immunology, have potential application in the development of more effective vaccines and anti-viral therapies.
Typically, when a person is infected with a virus, the human body immediately generates a massive number of T cells - a type of immune cell - that kill off the infected cells. Once the infection has cleared, most of the T cells also die off, leaving behind a small pool of central memory cells that “remember” how to fight that particular type of virus if the person is infected again.
“In this study, we have uncovered interferon’s role and the key signaling protein, called IL-2, involved in generating memory T cells,” said Dr. David Farrar, assistant professor of immunology at UT Southwestern and senior author of the study. “Knowing how T cells acquire this memory may help us design better strategies and vaccines to fight HIV and other infectious diseases. Further, our discovery was made using primary human CD4+ T cells, which underscores the relevance of our discovery to human immune responses.”
CD4+ T cells coordinate the actions of other cells at the site of infection.
When a virus or bacterium infects a human, the infected cells secrete several molecules, including a cytokine - or signaling protein - called interferon alpha. The action of interferon is what makes an infected person feel run down and tired. Although scientists knew that interferon alpha prevented a virus from multiplying and spreading, they didn’t know what role interferon played in the creation of memory cells.
In the current study, the UT Southwestern researchers show that both interferon alpha and another signaling protein called IL-12 are needed to induce the creation of memory cells. They found that interferon and IL-12 team up to promote the creation of a special set of cells that then secrete another signaling protein called IL-2. These IL-2-secreting cells are the ones that remain in the body and “remember” how to fight off the virus.
“Without the IL-2 signaling protein, you’ll generate a beautiful primary response against a virus, and you’ll eliminate the bug, but your body won’t remember how it defeated the virus,” Dr. Farrar said. “Without these memory cells, your body is defenseless against re-infections.”
Ann Davis, student research assistant in immunology and lead author of the study, said this suggests a new role for interferon: teacher.
“This is really the first demonstration of a role for interferon in teaching a T cell how to respond to viral infections,” she said.
Dr. Farrar added: “Up until now, interferon has always been appreciated for its role in inhibiting virus infections. But no one’s really paid attention to interferon and its role in regulating memory. That’s why we’re so excited about this result.”
The next step, Dr. Farrar said, is to complete the same study in mice. Early results show that mice with T cells that can’t respond to interferon are unable to protect themselves when a virus invades.
“Their immune systems have no idea how to fight the virus,” Dr. Farrar said.
Dr. Farrar said these early findings in mice may pave the way for designing more effective vaccines.
Other UT Southwestern researchers involved in the study were Hilario Ramos, student research assistant in immunology, and Dr. Laurie Davis, associate professor of internal medicine.
The National Institutes of Health supported the research.
A study from a team of researchers led by Dr. Andrew P. Makrigiannis, Director of the Molecular Immunology Research Unit at the IRCM, has identified a new mechanism regulating interferon production. This discovery, co-authored by scientists from the International Medical Center of Japan (Tokyo), the National Cancer Institute at Frederick (Maryland) and the McGill
Full Post: A new mechanism regulates type I interferon production in white blood cells
Bavituximab, an anti-viral drug developed by UT Southwestern Medical Center researchers, shows promise as a new strategy to fight viral diseases, including potential bioterrorism agents. In a study appearing in the December issue of Nature Medicine , groups of guinea pigs infected with a virus similar to Lassa fever virus recovered from the fatal disease
Full Post: Researchers develop new strategy for broad spectrum anti-viral drugs
Researchers at the University of Toronto and the University of California, San Francisco, have revealed new hope for HIV treatment with the discovery of a way to ‘rescue’ immune cells that are exhausted from fighting off HIV infection. The team lead by Drs. Mario Ostrowski, of the University of Toronto’s Faculty of Medicine, and Douglas
Full Post: Cells exhausted from fighting HIV infection can be rescued
Dieters or those who consume fewer calories during flu season could have a harder time fighting off the flu virus, according to research by Michigan State University nutritional immunology professor Elizabeth Gardner. In a study published in the November issue of the Journal of Nutrition, Gardner showed that mice with a calorie-restricted diet were more
Full Post: Dieters could have a harder time fighting flu
Like other kinds of cells, immune cells lose the ability to divide as they age because a part of their chromosomes known as a telomere becomes progressively shorter with cell division. As a result, the cell changes in many ways, and its disease fighting ability is compromised. But a new UCLA AIDS Institute study has
Full Post: Astragalus root plant chemical used to fight HIV